Skip to content
Clinical Trials – home
Verifiedinfo

Clinique Pasteur

France 45 Avenue De Lombez, Cs 27617, 31076 Toulouse, France

  • 27 trials recruiting
  • Atrial fibrillation · Prostate cancer · Hormone receptor positive HER2 negative breast cancer
  • Adult patients

About Specializations

Clinique Pasteur in Toulouse, France specialises in clinical trials of conditions such as Atrial fibrillation, Prostate cancer, Hormone receptor positive HER2 negative breast cancer, Crohn's disease, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, focusing on innovative treatments for various types of cancer. The center's work in this field is characterized by its commitment to improving patient outcomes through cutting-edge therapies and personalized medicine.

  • Locally advanced anal squamous cell carcinoma
  • Oligometastatic hormone-sensitive prostate cancer
  • ER+/HER2- metastatic breast cancer
  • High-risk biochemically-relapsed prostate adenocarcinoma
  • PD-L1-positive recurrent or metastatic head and neck squamous cell carcinomas

Through its research, the center is pioneering new approaches in chemotherapy, radiotherapy, and immunotherapy, offering hope to patients with challenging cancer diagnoses.

Cardiology

In the realm of cardiology, the center is dedicated to advancing the understanding and treatment of cardiovascular diseases. Its research initiatives are aimed at developing novel therapeutic strategies to manage and prevent heart-related conditions.

  • Hypertension
  • Excessive supraventricular ectopies or short atrial runs
  • Transfemoral trans-aortic valve implantation (TAVI)

The center's contributions to cardiovascular research are instrumental in shaping future clinical practices and improving patient care.

Endocrinology

The center's endocrinology research is focused on understanding the complex interactions of hormones and their impact on health. This research is crucial for developing effective treatments for endocrine disorders.

  • Primary Biliary Cholangitis
  • Prostatic adenocarcinoma with high risk of recurrence

By exploring the underlying mechanisms of endocrine diseases, the center is paving the way for innovative therapies that address the root causes of these conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
45 Avenue De Lombez, Cs 2761731076 ToulouseFrance
Recruiting now
27 trials
Conditions studied
49
Partner status
Verified

More sites in ToulouseFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

57 clinical trials

Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bio89-100
  • Sponsor:89bio Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bio89-100
  • Sponsor:89bio Inc.
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Guselkumab
  • Sponsor:Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Amgen Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:AZD5335
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pertuzumab
  • Sponsor:Solti Group
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sacituzumab Govitecan
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.